Shandong Sinobioway Biomedicine Co Ltd Net Asset Momentum
Shandong Sinobioway Biomedicine Co Ltd net asset momentum. Shandong Sinobioway Biomedicine Co Ltd (002581) recorded a net asset momentum of -3.8% as of December 2025, with net assets of CN¥1.95 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore Shandong Sinobioway Biomedicine Co Ltd (002581) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of Shandong Sinobioway Biomedicine Co Ltd (2007–2025)
Net asset momentum of Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025. This chart tracks Shandong Sinobioway Biomedicine Co Ltd's year-over-year net asset growth across 19 annual reporting periods from 2007 to 2025. The most recent momentum reading is -3.8%, with net assets of CN¥1.95 Billion CNY as of December 2025. See 002581 net asset value for net asset value and shareholders' equity analysis.
Shandong Sinobioway Biomedicine Co Ltd Net Asset Momentum by Year (2007–2025)
Shandong Sinobioway Biomedicine Co Ltd net asset momentum by year from 2007 to 2025. The table below shows the complete annual net asset history for Shandong Sinobioway Biomedicine Co Ltd from 2007 to 2025, covering 19 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see market cap of Shandong Sinobioway Biomedicine Co Ltd.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.95 Billion | CN¥2.17 Billion | CN¥222.00 Million | ▼ -3.8% |
| 2024 | CN¥2.02 Billion | CN¥2.20 Billion | CN¥173.61 Million | ▼ -7.0% |
| 2023 | CN¥2.17 Billion | CN¥2.34 Billion | CN¥163.41 Million | ▼ -11.9% |
| 2022 | CN¥2.47 Billion | CN¥2.86 Billion | CN¥389.46 Million | ▼ 0.0% |
| 2021 | CN¥2.47 Billion | CN¥2.76 Billion | CN¥286.76 Million | ▲ +12.7% |
| 2020 | CN¥2.19 Billion | CN¥2.44 Billion | CN¥254.33 Million | ▼ -8.3% |
| 2019 | CN¥2.39 Billion | CN¥3.41 Billion | CN¥1.03 Billion | ▼ -15.3% |
| 2018 | CN¥2.82 Billion | CN¥4.29 Billion | CN¥1.47 Billion | ▼ -3.4% |
| 2017 | CN¥2.92 Billion | CN¥4.00 Billion | CN¥1.08 Billion | ▲ +15.5% |
| 2016 | CN¥2.53 Billion | CN¥2.69 Billion | CN¥160.16 Million | ▲ +17.9% |
| 2015 | CN¥2.14 Billion | CN¥2.42 Billion | CN¥271.92 Million | ▲ +186.1% |
| 2014 | CN¥749.40 Million | CN¥769.49 Million | CN¥20.08 Million | ▲ +1.5% |
| 2013 | CN¥738.31 Million | CN¥773.80 Million | CN¥35.49 Million | ▲ +4.8% |
| 2012 | CN¥704.41 Million | CN¥729.02 Million | CN¥24.62 Million | ▲ +4.8% |
| 2011 | CN¥672.28 Million | CN¥690.19 Million | CN¥17.91 Million | ▲ +279.1% |
| 2010 | CN¥177.34 Million | CN¥209.68 Million | CN¥32.34 Million | ▲ +36.7% |
| 2009 | CN¥129.71 Million | CN¥164.95 Million | CN¥35.24 Million | ▲ +11.7% |
| 2008 | CN¥116.12 Million | CN¥143.53 Million | CN¥27.41 Million | ▲ +38.3% |
| 2007 | CN¥83.94 Million | CN¥95.54 Million | CN¥11.60 Million | — |